FrancophonIA/ELRC3.0 huggingface dataset:
English: The increased exposure of tenofovir could potentiate tenofovir associated adverse events, including renal disorders.
Croatian: Povećana izloženost tenofoviru mogla bi pojačati nuspojave povezane s tenofovirom,
English: Increased plasma concentrations of tenofovir resulting from coadministration of tenofovir disoproxil, ledipasvir/sofosbuvir and darunavir/ritonavir may increase adverse reactions related to tenofovir disoproxil, including renal disorders.
Croatian: Povećane koncentracije tenofovira u plazmi uslijed istovremene primjene tenofovirdizoproksila, ledipasvira/sofosbuvira i darunavira/ritonavira mogu pojačati nuspojave povezane s tenofovirdizoproksilom, uključujući poremećaje bubrega.
English: Lopinavir/ritonavir/emtricitabine Interaction not studied.
Croatian: Lopinavir/ritonavir/emtricitabin
English: Cmin: ↑ 42% (↑ 34 to ↑ 49) Atazanavir:
Croatian: Cmin: ↑ 42% (↑ 34 - ↑
English: • Emtricitabine/Tenofovir disoproxil Zentiva is used to treat Human Immunodeficiency
Croatian: • Emtricitabine/Tenofovir disoproxil Zentiva primjenjuje se za liječenje infekcije virusom humane imunodeficijencije tipa 1 (HIV-1) u odraslih.
English: BMD Z-scores declined by -0.012 for lumbar spine and by -0.338 for total body in the 64 subjects who were treated with tenofovir disoproxil for 96 weeks.
Croatian: U 64 ispitanika koji su primali tenofovirdizoproksil tijekom 96 tjedana z-vrijednosti BMD-a smanjile su se za -0,012 u području lumbalne kralježnice, a z-vrijednosti BMD-a cijelog tijela smanjile su se za -0,338. z vrijednosti BMD-a nisu prilagođene s obzirom na visinu i težinu.
English: Polyvinyl alcohol
Croatian: NARKOTIČKI ANALGETICI
English: • If you notice within 12 hours of the time you usually take Emtricitabine/Tenofovir disoproxil Zentiva, take the tablet preferably with food as soon as possible.
Croatian: Emtricitabine/Tenofovir disoproxil Zentiva, uzmite tabletu čim prije, po mogućnosti s hranom.
English: The safety of tenofovir disoproxil when used with sofosbuvir/velpatasvir/voxilaprevir and a pharmacokinetic enhancer (e.g. ritonavir or cobicistat) has not been established.
Croatian: Sigurnost tenofovirdizoproksila pri istovremenoj primjeni sa sofosbuvirom/velpatasvirom/voksilaprevirom i farmakokinetičkim pojačivačem (npr.
English: While taking Emtricitabine/Tenofovir disoproxil Zentiva to treat HIV or to reduce the risk of getting HIV:
Croatian: Dok uzimate lijek Emtricitabine/Tenofovir disoproxil Zentiva za smanjenje rizika od dobivanja HIV-a:
English: Cmax: ↑ 25% (↑ 8 to ↑ 45) Cmin: ↔
Croatian: AUC: ↔ Cmax: ↑ 25% (↑ 8 - ↑
English: Cmin: ↑ 63% (↑ 45 to ↑ 84) Ritonavir:
Croatian: Cmin: ↑ 63% (↑ 45 - ↑
English: • You must be HIV negative before you start to take Emtricitabine/Tenofovir disoproxil
Croatian: Što morate znati prije nego počnete uzimati Emtricitabine/Tenofovir disoproxil Zentiva
English: Gastrointestinal disorders Very common diarrhoea, nausea diarrhoea, vomiting, nausea
Croatian: duboko, ubrzano disanje omamljenost mučnina, povraćanje bol u trbuhu
English: Cmax: ↑ 42% (↑ 27 to ↑ 57) Cmin: ↔
Croatian: Cmin: ↑ 45% (↑ 27 - ↑
English: Emtricitabine/Tenofovir disoproxil Zentiva is also indicated for the treatment of HIV-1 infected adolescents, with NRTI resistance or toxicities precluding the use of first line agents (see sections 4.2, 4.4 and 5.1).
Croatian: NRTIs) ili toksičnošću koja onemogućuje primjenu lijekova prve linije (vidjeti dijelove 4.2, 4.4 i 5.1).
English: Cmin: ↑ 48% (↑ 34 to ↑ 63) Emtricitabine:
Croatian: Cmin: ↑ 48% (↑ 34 - ↑
English: Film-coating
Croatian: Serokonverzije /
English: Indication'
Croatian: Doziranje
English: NRTIs
Croatian: Spol
English: Darunavir / ritonavir / tenofovir disoproxil (300 mg q.d./100 mg q.d./
Croatian: Darunavir / ritonavir / tenofovirdizoproksil (300 mg jedanput na dan / 100 mg jedanput na dan / 245 mg jedanput na dan)
English: EU-Numbers
Croatian: Broj (EU) odobrenja
English: Invented name Strength Pharmaceutical Form Route of administration Packaging Content (concentration) Package sizes EU/1/01/173/001 Vaniqa
Croatian: Put primjene Unutarnje pakiranje
English: This overview was last updated in 06-2018
Croatian: Ovaj pregled informacija posljednji je put ažuriran u 06. 2018.
English: The starting dose is 15 mg once a day.
Croatian: Početna doza je 15 mg jedanput na dan.
English: Further information on Samsca can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Više informacija o lijeku Samsca nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This means that it blocks one type of receptor (target) to which the hormone vasopressin normally attaches itself.
Croatian: To znači da blokira jednu vrstu receptora (ciljni receptor) na koje se hormon vazopresin uobičajeno veže.
English: The only major safety concerns seen with this medicine came from animal studies suggesting it could be harmful to unborn babies.
Croatian: Jedini razlog za ozbiljnu zabrinutost zabilježen kod ovog lijeka potječe iz ispitivanja na životinjama i upućuje na to da bi mogao biti štetan za nerođenu djecu.
English: Samsca is available as tablets (7.5, 15 and 30 mg).
Croatian: Lijek Samsca dostupan je u obliku tableta (7,5 mg, 15 mg i 30 mg).
English: Normal sodium levels are between 135 and 145 mmol/l.
Croatian: Normalne razine natrija jesu od 135 do 145 mmol/l.
English: By blocking this receptor, Samsca prevents vasopressin's effect.
Croatian: Blokiranjem tog receptora lijek Samsca sprječava učinak vazopresina.
English: What is Samsca and what is it used for?
Croatian: Što je Samsca i za što se primjenjuje?
English: What measures are being taken to ensure the safe and effective use of Samsca?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Samsca?
English: Other information about Samsca
Croatian: Ostale informacije o lijeku Samsca
English: This may be increased to a maximum of 60 mg once a day to achieve an appropriate level of blood sodium and blood volume.
Croatian: Ona se može povećati do 60 mg jedanput na dan kako bi se postigla odgovarajuća razina natrija u krvi i volumena krvi.
English: What are the risks associated with Samsca?
Croatian: Koji su rizici povezani s lijekom Samsca?
English: Why is Samsca authorised in the EU?
Croatian: Zašto je lijek Samsca odobren u EU-u?
English: However, Samsca was more effective in patients with SIADH than in those with liver or heart problems.
Croatian: Međutim, lijek Samsca bio je učinkovitiji u bolesnika sa SIADH-om nego u onih koji imaju probleme s jetrom ili srcem.
English: Side effects reported with Samsca are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Samsca pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: This medicine must therefore not be used in women who are pregnant or breastfeeding.
Croatian: Stoga ovaj lijek ne smiju primjenjivati trudnice ni dojilje.
English: A dose of 7.5 mg once a day can be used for patients at risk of excessively quick rise in blood sodium.
Croatian: Doza od 7,5 mg jedanput na dan može se primjenjivati u bolesnika kod kojih postoji rizik od prebrzog povećanja razine natrija u krvi.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Samsca have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Samsca nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: Two studies involving 424 adults showed that Samsca is effective at increasing sodium levels in patients with low levels caused by SIADH and other conditions such as liver and heart problems.
Croatian: Dva ispitivanja koja su obuhvaćala 424 odrasle osobe pokazala su da je lijek Samsca djelotvoran u povećavanju razina natrija u bolesnika s niskim razinama natrija koje su uzrokovane SIADH-om ili drugim oboljenjima kao što su problemi s jetrom i srcem.
English: Treatment with Samsca should be started in hospital so that healthcare professionals can determine the most appropriate dose and monitor the patient's level of blood sodium and blood volume.
Croatian: Liječenje lijekom Samsca treba započeti u bolnici kako bi zdravstveni radnici mogli utvrditi najprimjereniju dozu i nadzirati razinu natrija u krvi i volumen krvi bolesnika.
English: The European Medicines Agency concluded that Samsca's benefits are greater than its risks and that it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi lijeka Samsca nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u Europskoj uniji.
English: The most common side effects with Samsca (which may affect more than 1 patient in 10) are thirst, nausea (feeling sick) and sodium levels rising too quickly.
Croatian: Najčešće nuspojave lijeka Samsca (koje se mogu javiti u više od 1 na 10 bolesnika) su žeđ, mučnina (osjećaj slabosti) i prebrzo povećanje razina natrija.
English: As for all medicines, data on the use of Samsca are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Samsca kontinuirano se prate.
English: The active substance in Samsca, tolvaptan, is a ‘vasopressin-2 receptor antagonist'.
Croatian: Djelatna tvar lijeka Samsca, tolvaptan, antagonist je vazopresinskih V2 receptora.
English: An overview of Samsca and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Samsca i zašto je odobren u EU-u
English: Samsca is a medicine for treating abnormally low levels of sodium in the blood in adults with a condition called ‘syndrome of inappropriate antidiuretic hormone secretion' (SIADH).
Croatian: Samsca je lijek za liječenje abnormalno niskih razina natrija u krvi u odraslih osoba koje boluju od sindroma neodgovarajućeg izlučivanja antidiuretskog hormona (SIADH).
English: By day 30, sodium had increased by an average of 7.4 mmol/l in patients who took Samsca, compared with 1.5 mmol/l in patients receiving placebo.
Croatian: Do 30. dana povećanje razina natrija iznosilo je u prosjeku 7,4 mmol/l u bolesnika koji su primili lijek Samsca, u usporedbi s 1,5 mmol/l u bolesnika koji su primili placebo.
English: In patients with SIADH, sodium levels, which were around 129 mmol/l at the start of treatment, rose by an average of 4.8 mmol/l by day 4 in those who took Samsca, compared with 0.2 mmol/l in those who took placebo (dummy treatment).
Croatian: Razine natrija u bolesnika sa SIADH-om na početku liječenja bile su otprilike 129 mmol/l te su se do četvrtog dana liječenja u prosjeku povećale za 4,8 mmol/l u onih koji su primili lijek Samsca, u usporedbi s 0,2 mmol/l u onih koji su primili placebo (prividno liječenje).
English: This increases urine production, decreasing the amount of water in the blood and increasing the blood sodium level.
Croatian: Time se povećava stvaranje urina te se smanjuje količina vode u krvi, a povećava razina natrija u krvi.
English: For more information about using Samsca, see the package leaflet or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Samsca pročitajte u uputi o lijeku, odnosno obratite se liječniku ili ljekarniku.
English: Samsca received a marketing authorisation valid throughout the European Union on 3 August
Croatian: Lijek Samsca dobio je odobrenje za stavljanje lijeka u promet koje je na snazi u EU-u od 3. kolovoza 2009.
English: Samsca has been shown to be effective at increasing sodium levels, particularly in patients with SIADH.
Croatian: Lijek Samsca pokazao se učinkovitim u povećavanju razina natrija, osobito u bolesnika oboljelih od SIADH-a.
English: Samsca must also not be used in women who are pregnant or breast-feeding.
Croatian: Lijek Samsca također ne smiju primjenjivati trudnice ni dojilje.
English: Samsca must not be used in patients with anuria (an inability to pass urine), very low blood volume, low blood sodium levels with low blood volume, hypernatremia (abnormally high levels of sodium in the blood) or in patients who cannot perceive thirst.
Croatian: Lijek Samsca ne smije se primjenjivati u bolesnika s anurijom (nemogućnost mokrenja), vrlo niskim volumenom krvi, niskim razinama natrija u krvi pri niskom volumenu krvi, hipernatremijom (abnormalno visoke razine natrija u krvi) ili u bolesnika koji ne osjećaju žeđ. Lijek se ne smije primjenjivati u bolesnika koji su alergični na tolvaptan ili lijekove koji su slični tolvaptanu, takozvane benzazepine ili njihove derivate.
English: In SIADH, an excessive amount of the hormone vasopressin makes the patient produce less urine and thereby retain more water in the body, which dilutes the concentration of sodium in the blood.
Croatian: Prekomjerna količina hormona vazopresina u bolesnika sa SIADH-om dovodi do smanjenog stvaranja urina te se zbog toga u tijelu zadržava više vode, koja razrjeđuje koncentraciju natrija u krvi.
English: What benefits of Samsca have been shown in studies?
Croatian: Koje su koristi od lijeka Samsca utvrđene u ispitivanjima?
English: How does Samsca work?
Croatian: Kako djeluje Samsca?
English: People with SIADH have an excessive amount of vasopressin, leading to decreased urine production and dilution of the blood.
Croatian: Prekomjerna količina vazopresina u osoba oboljelih od SIADH-a dovodi do smanjenog stvaranja urina i razrjeđivanja krvi.
English: Samsca contains the active substance tolvaptan.
Croatian: Lijek Samsca sadrži djelatnu tvar tolvaptan.
English: For the full list of side effects reported with Samsca, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Samsca potražite u uputi o lijeku.
English: How is Samsca used?
Croatian: Kako se Samsca primjenjuje?
English: 28 days.
Croatian: 28 dana.
English: Please ask your doctor how this may affect you, especially if you are planning to have children in the future.
Croatian: Pitajte svog liječnika kako to može djelovati na Vas, osobito ako u budućnosti planirate imati djecu.
English: It will only be used in special controlled areas.
Croatian: Primjenjivat će se samo u posebnim kontroliranim prostorima.
English: The dose you receive depends on your body weight.
Croatian: Doza koju primate ovisi o Vašoj tjelesnoj težini.
English: Date of first authorisation: 13 November 2013 Date of latest renewal: 21 June 2018
Croatian: Datum prvog odobrenja: 13. studeni 2013 Datum posljednje obnove odobrenja: 21. lipnja 2018.
English: This booklet was last revised in {MM/YYYY}.
Croatian: Ova knjižica je zadnji puta revidirana u {MM/GGGG}.
English: • the mean age of patients was 70 years (range 49 to 90 years).
Croatian: • srednja dob bolesnika bila je 70 godina (raspon od 49 do 90 godina).
English: PSA progression d
Croatian: Progresija PSA d
English: Total ALP progression c
Croatian: Ukupna progresija ALP c
English: Appropriate aseptic precautions should be taken.
Croatian: Potrebno je primjenjivati odgovarajuće aseptičke mjere opreza.
English: It must be administered by slow injection (generally up to 1 minute).
Croatian: Mora se primjenjivati sporom injekcijom (općenito u trajanju do 1 minute).
English: Drammensveien 288 NO-0283 Oslo Norway
Croatian: Drammensveien 288 NO-0283 Oslo Norveška
English: Both groups experience a loss of quality of life.
Croatian: U obje grupe zabilježeno je smanjenje kvalitete života.
English: Their receipt, storage, use, transfer and disposal are subject to the regulations and/or appropriate licenses of the competent official organisation.
Croatian: Njihovo primanje, čuvanje, uporaba, prijenos i zbrinjavanje podliježu propisima i/ili odgovarajućim odobrenjima nadležnih službenih tijela.
English: The doctor will tell you if you need to take any special precautions after receiving this medicine.
Croatian: Liječnik će Vas obavijestiti ako trebate poduzeti neke posebne mjere opreza nakon primanja ovog lijeka.
English: As the updated analysis is provided for descriptive purposes only, a p-value is not provided.
Croatian: Budući da je ažurirana analiza prikazana samo u opisne svrhe, nije ponuđena p-vrijednost.
English: The total volume to be administered to a patient is calculated as follows:
Croatian: Ukupni volumen koji će se primijeniti bolesniku izračunava se na sljedeći način:
English: The volume of distribution was higher than the blood volume indicating distribution to peripheral compartments.
Croatian: Volumen distribucije bio je veći od volumena krvi, što ukazuje na distribuciju u periferne odjeljke.
English: Each vial is for single use only.
Croatian: Svaka bočica je namijenjena samo za jednokratnu uporabu.
English: Tell your doctor if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Croatian: Obavijestite svog liječnika ako uzimate ili ste nedavno uzeli ili biste mogli uzeti bilo koje druge lijekove, uključujući lijekove koje ste nabavili bez recepta.
English: • 41% received bisphosphonates.
Croatian: • 41% primalo je bisfosfonate.
English: The primary efficacy endpoint was overall survival.
Croatian: Primarni ishod djelotvornosti bilo je ukupno preživljenje.
English: The clinical relevance of these findings is unknown.
Croatian: Klinički značaj ovih saznanja nije poznat.
English: Depending on the results of these tests your doctor will decide if treatment can be started, can be continued, or needs to be postponed or discontinued.
Croatian: Ovisno o rezultatima ovih pretraga, liječnik će odlučiti može li se početi s liječenjem, može li se liječenje nastaviti ili ga treba odgoditi ili prekinuti.
English: Coefficient of variation
Croatian: Koeficijent varijacije
English: In general, radionuclides are considered to be genotoxic and carcinogenic.
Croatian: Općenito se radionuklidi smatraju genotoksičnima i kancerogenima.
English: No dose adjustment is necessary if you are 65 years of age or older or if you have reduced kidney or liver function.
Croatian: Nije potrebna prilagodba doze ako ste u dobi od 65 godina ili stariji ili ako imate oslabljenu funkciju bubrega ili jetre.
English: These persons will take special care for the safe use of this product and will keep you informed of their actions.
Croatian: Te će osobe obratiti posebnu pozornost na sigurnu primjenu ovog lijeka i obavještavat će Vas o svojim postupcima.
English: If you are already taking one of those medicines, please tell your doctor.
Croatian: Ako već uzimate neki od tih lijekova, recite to svom liječniku.
English: Xofigo is not indicated in women.
Croatian: Xofigo nije indiciran u žena.
English: About 5% is excreted in the urine and there is no evidence of hepatobiliary excretion.
Croatian: Oko 5% izlučuje se mokraćom i nema dokaza hepatobilijarnog izlučivanja.
English: Since humans do not have a tapetum lucidum, the clinical relevance of these findings for humans is uncertain.
Croatian: Budući da ljudi nemaju tapetum lucidum, nije sigurno koja je klinička važnost ovih nalaza za ljude.
English: Fifteen minutes post injection, about 20% of the injected activity remained in the blood.
Croatian: Petnaest minuta nakon injekcije, oko 20% ubrizgane aktivnosti ostalo je u krvi.
English: For additional instructions on the use of the medicinal product, see sections 6.6 and 12.
Croatian: Za dodatne upute o primjeni lijeka vidjeti dijelove 6.6 i 12.
English: Your doctor will perform blood tests before starting treatment and before each injection to check your number of blood cells and platelets (see also section 2).
Croatian: Liječnik će Vam napraviti krvne pretrage prije početka liječenja i prije svake injekcije kako bi provjerio broj krvnih stanica i pločica (vidjeti također dio 2).
English: Duration of the procedure - Xofigo is given once every 4 weeks for a total of 6 injections.
Croatian: Trajanje postupka - Xofigo se daje jedanput svaka 4 tjedna do ukupno 6 injekcija.
English: Surgical intervention 9
Croatian: Kirurška intervencija 9
English: Faecal excretion is the major route of elimination from the body.
Croatian: Izlučivanje stolicom glavni je put eliminacije iz tijela.
English: The whole body measurements at 7 days after injection (after correcting for decay) indicate that a median of 76% of administered activity was excreted from the body.
Croatian: Mjerenja cijelog tijela 7 dana nakon injekcije (nakon korekcije za raspad) pokazala su da se iz tijela izlučio medijan od 76% primijenjene aktivnosti.
English: For details on the calculation of the volume to be administered see section 12.
Croatian: Za detalje o izračunavanju volumena za primjenu vidjeti dio 12.
English: The doctor supervising the procedure will calculate the quantity of Xofigo to be used in your case.
Croatian: Liječnik koji nadzire postupak izračunat će količinu lijeka Xofigo koju treba primijeniti u Vašem slučaju.
English: The specific activity of radium-223 is 1.9 MBq/ng.
Croatian: Specifična aktivnost radija-223 je 1,9 MBq/ng.
English: There are strict laws on the use, handling and disposal of medicines like Xofigo.
Croatian: Postoje strogi zakoni o primjeni, rukovanju i zbrinjavanju lijekova kao što je Xofigo.
English: Other possible side effects are listed below by how likely they are:
Croatian: Druge moguće nuspojave navedene su niže prema vjerojatnosti javljanja:
English: Fractures have occurred for up to 24 months after the first dose of radium-223.
Croatian: Prijelomi su se javljali do 24 mjeseca nakon prve doze radija-223.
English: At 10 minutes post injection, activity was observed in the bone and in the intestine.
Croatian: Deset minuta nakon injekcije, aktivnost je opažena u kostima i crijevima.
English: Studies on reproductive and developmental toxicity have not been performed.
Croatian: Nisu provedena ispitivanja reproduktivne i razvojne toksičnosti.
English: The testes seemed to otherwise be functioning normally and the epididymides revealed a normal content of spermatocytes.
Croatian: Činilo se da testisi inače funkcioniraju na normalnoj razini, a u pasjemeniku se otkrio normalan sadržaj spermatocita.
English: Patients who display signs or symptoms of dehydration or hypovolemia should be promptly treated.
Croatian: Bolesnike sa znakovima ili simptomima dehidracije ili hipovolemije treba bez odgode zbrinuti.
English: Q2 2024
Croatian: 2.kvartal 2024.
English: Radium-223 is an isotope which decays and is not metabolised.
Croatian: Radij-223 je izotop koji se raspada i ne metabolizira se.
English: Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100).
Croatian: Učestalosti su definirane na sljedeći način: vrlo često (≥ 1/10), često (≥ 1/100 do < 1/10), manje često (≥ 1/1000 do < 1/100).
English: No overall differences in safety or efficacy were observed between elderly (aged ≥ 65 years) and younger patients (aged < 65 years) in the phase III study.
Croatian: U cjelini gledano, nisu opažene razlike u sigurnosti i djelotvornosti primjene između starijih (u dobi od ≥ 65 godina) i mlađih bolesnika (u dobi < 65 godina) u ispitivanju faze III.
English: Figure 2: Kaplan-Meier overall survival curves (updated analysis)
Croatian: Slika 2: Kaplan-Meierove krivulje ukupnog preživljenja (ažurirana analiza)
English: Xofigo is administered as an intravenous injection and is thus 100% bioavailable.
Croatian: Xofigo se primjenjuje kao intravenska injekcija i stoga je njegova bioraspoloživost 100%.
English: Clear, colourless isotonic solution with pH between 6.0 and 8.0.
Croatian: Bistra, bezbojna izotonična otopina s pH između 6,0 i 8,0.
English: The absorbed radiation dose calculation was performed based on clinical biodistribution data.
Croatian: Izračunavanje apsorbirane doze zračenja provedeno je na temelju kliničkih podataka biodistribucije.
English: Interim analysis
Croatian: Privremena analiza
English: • 42% of patients did not receive prior docetaxel because they were deemed ineligible or refused to receive docetaxel.
Croatian: • 42% bolesnika nije prethodno primalo docetaksel, jer ih se je smatralo nepodobnima ili su odbili primati docetaksel.
English: In general, radionuclides induce reproductive and developmental effects.
Croatian: Općenito, radionuklidi utječu na reprodukciju i razvoj.